학술논문

Immortal time bias and infliximab-related mortality and malignancy incidence
Postscript
Document Type
Letter to the editor
Source
Gut. March 2010, Vol. 59 Issue 3, p416, 2 p.
Subject
Dosage and administration
Care and treatment
Patient outcomes
Infliximab -- Dosage and administration
Inflammatory bowel diseases -- Care and treatment
Inflammatory bowel diseases -- Patient outcomes
Language
English
ISSN
0017-5749